Bingham Private Wealth’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$913K Buy
7,105
+1,114
+19% +$130K 0.63% 46
2026
Q1
$720K Buy
5,991
+675
+13% +$77.9K 0.57% 51
2025
Q4
$560K Buy
+5,316
New +$499K 0.48% 60
2025
Q2
$335K Sell
4,227
-458
-10% -$36.4K 0.32% 97
2025
Q1
$421K Sell
4,685
-1,469
-24% -$137K 0.43% 77
2024
Q4
$612K Buy
+6,154
New +$634K 0.65% 45

Other funds holding MRK

Bingham Private Wealth's MRK Position: Q2 2026 in Review

Bingham Private Wealth increased its Merck (MRK) stake by 19% in Q2 2026, buying an estimated $130K and bringing the position to 7,105 shares worth $913K. The position accounts for 0.63% of the portfolio, ranked #46.

Bingham Private Wealth first reported a position in MRK in Q4 2024 and has held it in 6 quarters since. 3,841 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Bingham Private Wealth held 7,105 shares of Merck worth $913K as of Q2 2026.
  • Bingham Private Wealth bought 1,114 Merck shares in Q2 2026, an estimated $130K.
  • Merck made up 0.63% of Bingham Private Wealth's portfolio in Q2 2026, its #46 holding.
  • Bingham Private Wealth first reported a position in Merck in Q4 2024 and has held it in 6 quarters since.
  • 3,841 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Bingham Private Wealth's 13F filing for Q2 2026, filed 11 Aug 2026.